Corrigendum

Abstract

Diabetic MedicineVolume 38, Issue 8 e14599 CORRIGENDUMFree Access Corrigendum This article corrects the following: Young Diabetologist and Endocrinologist Forum Travel Award Volume 38Issue S1Diabetic Medicine First Published online: April 18, 2021 First published: 21 July 2021 https://doi.org/10.1111/dme.14599AboutSectionsPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat There were errors in the standard deviation values in the Results section of the Oral abstract entitled ‘A51 (P141) | Manchester Intermittent versus Daily diet Diabetes App Study (MIDDAS): Evaluation of medication cost’ by Huntriss et al.1 The correct values are presented below: Results: Average medication costs for diabetes and blood pressure for ILED were £497.71 ± 797.17 at baseline and £529.55 ± 959.93 at 52 weeks demonstrating a non-significant increase in costs by £31.84 per completer (p = 0.06). The CLED medication costs at baseline (£552.12 ± 1013.30) and 52 weeks (£210.45 ± 486.56) provided a significant cost-saving of £341.67 per completer (p = 0.03). The online version has been corrected. REFERENCE 1Abstracts of the Diabetes UK Professional Conference 2021, 19 to 30 April 2021, Online. Diabet Med. 2021; 38(Suppl 1):e14555. https://doi.org/10.1111/dme.14555Google Scholar Volume38, Issue8August 2021e14599 ReferencesRelatedInformation